Bright Minds Biosciences Income Statement (2020-2026) | DRUG

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Cost of Revenue (Quarter)	0.04M		0.08M	0.07M	0.01M		0.03M	0.07M	0.01M		0.05M	0.07M	0.01M		0.03M	0.08M	0.01M		0.11M	0.03M
Operating items
Research & Development (Quarter)	2.20M	1.75M	3.05M	2.96M	1.61M	1.95M	1.08M	1.03M	0.78M	0.81M	0.90M	0.08M	-0.41M	0.30M	0.75M	1.79M	1.94M	3.48M	4.06M	9.51M
Share-based Compensation (IS) (Quarter)	0.21M		0.21M	0.23M	0.23M		0.36M	0.02M	0.18M		0.16M	0.17M	0.13M		0.13M	0.43M	0.95M		0.92M
Selling, General & Administrative (Quarter)	0.04M	0.07M	0.17M	0.06M	0.07M	0.08M	0.05M	0.10M	0.09M	-0.03M	0.05M	0.04M	0.06M	0.04M	0.06M	0.19M	0.12M	0.19M	0.25M
Other Operating Expenses (Quarter)												0.31M	0.51M	0.23M	-0.77M	-4.39M	-6.38M	13.15M	-10.32M
Operating Expenses (Quarter)	2.25M	1.83M	3.22M	3.01M	1.68M	2.03M	1.12M	1.14M	0.87M	0.78M	0.95M	0.43M	0.16M	0.57M	0.03M	-2.41M	-4.31M	16.81M	-6.01M
Operating Income (Quarter)									-1.09M		-1.24M		0.16M		0.03M
EBIT (Quarter)									-1.09M		-1.24M		0.16M		0.03M
Non-operating items
Interest & Investment Income (Quarter)													0.01M	0.00M	0.00M	0.35M	0.34M	0.38M	0.59M
Other Non Operating Income (Quarter)	0.09M	0.17M	0.03M	0.01M	-0.00M	-0.15M	0.03M	-0.00M	0.01M	0.10M	0.03M	0.01M	0.01M	-0.02M	-1.17M	0.08M	1.93M	-0.48M	1.06M
Net income details
Profit After Tax (Quarter)	2.87M	-11.47M	3.85M	3.54M	2.09M	2.27M	-1.72M	-1.52M	-1.09M	-1.07M	-1.24M	-0.43M	0.17M	0.57M	0.04M	-2.06M	-3.78M	-2.97M	-5.42M
EBT (Quarter)									-1.09M		-1.24M		0.17M		0.04M
Tax Provisions (Quarter)																	0.19M	-0.19M
Income from Continuing Operations (Quarter)									-1.09M		-1.24M		0.17M		0.04M
Consolidated Net Income (Quarter)									-1.09M		-1.24M		0.17M		0.04M
Income towards Parent Company (Quarter)									-1.09M		-1.24M		0.17M		0.04M
Net Income towards Common Stockholders (Quarter)									-1.09M		-1.24M		0.17M		0.04M
Additional items
Shares Outstanding (Weighted Average) (Quarter)	585.74	1.88M	325.27	623.69	0.00M	2.70M	478.86	406.83	0.00M	2.81M	2.82M	400.74	36.56	124.62	7.16	306.64	64.89M	89.56M	5.57M
EPS (Basic) (Quarter)									-922.98		-0.44		0.00M		0.00M
EPS (Weighted Average and Diluted) (Quarter)									-0.39		-0.44		0.00M		0.00M
Shares Outstanding (Diluted Average) (Quarter)	9.21M	1.43M	9.39M	9.35M	9.30M	1.89M	478.86	406.83	2.81M	2.77M	2.82M	3.31M	36.56	124.62	7.16	4.91M	5.11M		5.57M
EBITDA (Quarter)									-1.09M		-1.24M		0.17M		0.04M				-5.42M

Research Tools

Developers

Bright Minds Biosciences Income Statement (2020-2026) | DRUG

Research Tools

Developers

Bright Minds Biosciences Income Statement (2020-2026) | DRUG

Create an account

Sign In

Reset Password